Kristien Ledeganck

9PUBLICATIONS
25CO-AUTHORS
Infant and child healthInnate immunityExercise physiologyGene and molecular therapyBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 30, 2023
Urinary epidermal growth factor reflects vascular health in boys with either obesity or type 1 diabetes. A role for renin, or beyond?

Kristien J Ledeganck, Annelies Van Eyck, Kristien Wouters

|May 11, 2022
Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis.

Arno Verleye, Veerle Wijtvliet, Steven Abrams

|May 09, 2022
Trends of glucose, lactate and ketones during anaerobic and aerobic exercise in subjects with type 1 diabetes: The ACTION-1 study.

Francesca De Ridder, Kristien J Ledeganck, Benedicte De Winter

|Dec 10, 2021
mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?

Veerle P W M Wijtvliet, Kevin K Ariën, Steven Abrams

|Sep 17, 2021
Relationship Between Time in Range, Glycemic Variability, HbA1c, and Complications in Adults With Type 1 Diabetes Mellitus.

Anass El Malahi, Michiel Van Elsen, Sara Charleer

|Jun 11, 2021
Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy.

Margot Geens, Sofie Stappers, Heleen Konings

Pageof 2

Frequent Collaborators

2 joint publications

Veerle Wijtvliet

2 joint publications

Karl Martin Wissing

2 joint publications

Benedicte Y De Winter

2 joint publications

Christophe De Block